Krishna Institute of Medical Sciences Ltd. (KIMS) fundamentals
Krishna Institute of Medical Sciences Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as KIMS (ISIN INE967H01025). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Krishna Institute of Medical Sciences Ltd. does
Krishna Institute of Medical Sciences Ltd is an India-based company, which is principally engaged in the business of rendering medical and healthcare services. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Company’s institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.
Valuation and market data
| Last close | ₹772.80 |
|---|---|
| Market capitalisation | ₹31,015 crore |
| Enterprise value | ₹34,920 crore |
| P/E (TTM) | 128.16 |
| Price to book | 12.12 |
| Price to sales (TTM) | 4.39 |
| Book value per share | ₹63.75 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon Jun 28 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹3,931 crore | ₹334 crore | ₹242 crore | 6.03 |
| Mar 2025 | ₹3,067 crore | ₹558 crore | ₹415 crore | 9.61 |
| Mar 2024 | ₹2,514 crore | ₹460 crore | ₹336 crore | 7.75 |
| Mar 2023 | ₹2,224 crore | ₹485 crore | ₹366 crore | 42.03 |
| Mar 2022 | ₹1,671 crore | ₹457 crore | ₹344 crore | 41.88 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 32.5% |
|---|---|
| Foreign institutions (FII) | 14.7% |
| Mutual funds | 28.5% |
| Other domestic institutions | 5.9% |
| Retail and others | 18.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.